WT1-p53 Interactions in Insulin-like Growth Factor-I Receptor Gene Regulation

This publication has 30 references indexed in Scilit:

• Regulation of Insulin-Like Growth Factor I Receptor Promoter Activity by Wild-Type and Mutant Versions of the WT1 Tumor Suppressor
  Endocrinology, 1999
• Requirement for p53 and p21 to Sustain G ₂ Arrest After DNA Damage
  Science, 1998
• p53 Regulates Insulin-Like Growth Factor-I (IGF-I) Receptor Expression and IGF-I-Induced Tyrosine Phosphorylation in an Osteosarcoma Cell Line: Interaction between p53 and Sp1
  Endocrinology, 1998
• The Insulin-Like Growth Factor-I Receptor Signaling Pathways Are Important for Tumorigenesis and Inhibition of Apoptosis
  Critical Reviews™ in Oncogenesis, 1997
• Regulation of insulin-like growth factor I receptor gene expression by Sp1: physical and functional interactions of Sp1 at GC boxes and at a CT element
  Molecular Endocrinology, 1995
• The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
  Genes & Development, 1995
• Structural and functional analysis of the insulin-like growth factor I receptor gene promoter
  Molecular Endocrinology, 1992
• Aberrant expression of the tumour suppressor gene p53 is very frequent in Wilms' tumours
  The Journal of Pathology, 1992
• p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts.
  Genes & Development, 1991
• Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
  Cell, 1990